Terms: = Sarcomas AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Treatment
85 results:
1. SAKK57/16 Nab-paclitaxel and Gemcitabine in Soft Tissue Sarcoma (NAPAGE): a phase I/II trial.
Digklia A; Kollár A; Dietrich D; Kronig MN; Britschgi C; Rordorf T; Joerger M; Krasniqi F; Metaxas Y; Colombo I; Ribi K; Rothermundt C
Eur J Cancer; 2024 Jan; 197():113470. PubMed ID: 38096656
[TBL] [Abstract] [Full Text] [Related]
2. Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours.
Leary A; Oaknin A; Trigo JM; Moreno V; Delord JP; Boni V; Braña I; Fernández C; Kahatt C; Nieto A; Cullell-Young M; Zeaiter A; Subbiah V
Eur J Cancer; 2023 Oct; 192():113259. PubMed ID: 37634282
[TBL] [Abstract] [Full Text] [Related]
3. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Pearson ADJ; Federico S; Gatz SA; Ortiz M; Lesa G; Scobie N; Gounaris I; Weiner SL; Weigel B; Unger TJ; Stewart E; Smith M; Slotkin EK; Reaman G; Pappo A; Nysom K; Norga K; McDonough J; Marshall LV; Ludwinski D; Ligas F; Karres D; Kool M; Horner TJ; Henssen A; Heenen D; Hawkins DS; Gore L; Bender JG; Galluzzo S; Fox E; de Rojas T; Davies BR; Chakrabarti J; Carmichael J; Bradford D; Blanc P; Bernardi R; Benchetrit S; Akindele K; Vassal G
Eur J Cancer; 2023 Sep; 190():112950. PubMed ID: 37441939
[TBL] [Abstract] [Full Text] [Related]
4. Clinical characteristics and outcomes for children, adolescents and young adults with "CIC-fused" or "BCOR-rearranged" soft tissue sarcomas: A multi-institutional European retrospective analysis.
Sparber-Sauer M; Corradini N; Affinita MC; Milano GM; Pierron G; Carton M; Tirode F; Pissaloux D; Alaggio R; Vokuhl C; Bisogno G; Berlanga P; Ferrari A; Orbach D
Cancer Med; 2023 Jul; 12(13):14346-14359. PubMed ID: 37212486
[TBL] [Abstract] [Full Text] [Related]
5. Germline drivers of gynecologic carcinosarcomas.
Sia TY; Gordhandas SB; Birsoy O; Kemel Y; Maio A; Salo-Mullen E; Sheehan M; Hensley ML; Rubinstein M; Makker V; Grisham RN; O'Cearbhaill RE; Roche KL; Mueller JJ; Leitao MM; Sonoda Y; Chi DS; Abu-Rustum NR; Berger MF; Ellenson LH; Latham A; Stadler Z; Offit K; Aghajanian C; Weigelt B; Mandelker D; Liu YL
Gynecol Oncol; 2023 Jul; 174():34-41. PubMed ID: 37149903
[TBL] [Abstract] [Full Text] [Related]
6. Risk of obstetric and perinatal complications in women presenting with breast cancer during pregnancy and the first year postpartum in Sweden 1973-2017: A population-based matched study.
Lundberg FE; Gkekos L; Rodriguez-Wallberg KA; Fredriksson I; Johansson ALV
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):684-694. PubMed ID: 36959086
[TBL] [Abstract] [Full Text] [Related]
7. What is the Value of Radiology Input During a Multidisciplinary Orthopaedic Oncology Conference?
Komarraju A; Van Rilland EZ; Gebhardt MC; Anderson ME; Heincelman C; Wu JS
Clin Orthop Relat Res; 2023 Oct; 481(10):2005-2013. PubMed ID: 36929904
[TBL] [Abstract] [Full Text] [Related]
8. Relationship between PET/CT images and KRAS gene mutations in colorectal cancer in Vietnamese patients.
Dan NV; Phuong PC; Thai PV; Nguyen NH; Loi NT; Cong BT
Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1480-1486. PubMed ID: 36876696
[TBL] [Abstract] [Full Text] [Related]
9. The BRCAness Landscape of Cancer.
Guo M; Wang SM
Cells; 2022 Dec; 11(23):. PubMed ID: 36497135
[TBL] [Abstract] [Full Text] [Related]
10. Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?
Rémond MS; Pellat A; Brezault C; Dhooge M; Coriat R
ESMO Open; 2022 Dec; 7(6):100638. PubMed ID: 36399952
[TBL] [Abstract] [Full Text] [Related]
11. brca1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma.
Maurer LM; Daley JD; Mukherjee E; Venier RE; Julian CM; Bailey NG; Jacobs MF; Kumar-Sinha C; Raphael H; Periyapatna N; Weiss K; Janeway KA; Mody R; Lucas PC; McAllister-Lucas LM; Bailey KM
Cancer Res Commun; 2022 Apr; 2(4):220-232. PubMed ID: 36187937
[TBL] [Abstract] [Full Text] [Related]
12. Therapeutic targeting of ATR in alveolar rhabdomyosarcoma.
Dorado García H; Pusch F; Bei Y; von Stebut J; Ibáñez G; Guillan K; Imami K; Gürgen D; Rolff J; Helmsauer K; Meyer-Liesener S; Timme N; Bardinet V; Chamorro González R; MacArthur IC; Chen CY; Schulz J; Wengner AM; Furth C; Lala B; Eggert A; Seifert G; Hundsoerfer P; Kirchner M; Mertins P; Selbach M; Lissat A; Dubois F; Horst D; Schulte JH; Spuler S; You D; Dela Cruz F; Kung AL; Haase K; DiVirgilio M; Scheer M; Ortiz MV; Henssen AG
Nat Commun; 2022 Jul; 13(1):4297. PubMed ID: 35879366
[TBL] [Abstract] [Full Text] [Related]
13. Primary central nervous system histiocytic sarcoma with somatic
Wang W; Zhang Y; Dong Y; Li S; Qin H
Clin Neuropathol; 2022; 41(6):253-262. PubMed ID: 35652545
[TBL] [Abstract] [Full Text] [Related]
14. Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing.
Peng C; Jian X; Xie Y; Li L; Ouyang J; Tang L; Zhang X; Su J; Zhao S; Liu H; Yin M; Wu D; Wan M; Xie L; Chen X
Br J Dermatol; 2022 Jun; 186(6):997-1009. PubMed ID: 35441365
[TBL] [Abstract] [Full Text] [Related]
15. Hidden in the Eyes-Recurrence of Systemic Hemopathies Reportedly "In Remission": Six Cases and Review of Literature.
Denier M; Tick S; Dubois R; Dulery R; Eller AW; Suarez F; Burroni B; Maurage CA; Bories C; Konopacki J; Puech M; Bouscary D; Cantalloube A; Héron E; Marçais A; Habas C; Theillac V; Keilani C; Bonhomme GR; Gallagher DS; Boumendil J; Abarah W; Sedira N; Bertin S; Choquet S; Sahel JA; Merabet L; Brignole-Baudouin F; Putterman M; Errera MH
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334633
[No Abstract] [Full Text] [Related]
16. Study of 172 Cases of AIDS Associated Cancers.
Phatak UA; Gosavi VS; Chitale PV
J Assoc Physicians India; 2022 Jan; 70(1):11-12. PubMed ID: 35062808
[TBL] [Abstract] [Full Text] [Related]
17. Mortality disparities among patients with HIV-associated Kaposi's sarcoma in the southern United States.
Knights SM; Lazarte SM; Kainthla R; Chiao EY; Nijhawan AE
AIDS; 2022 Apr; 36(5):721-728. PubMed ID: 34930860
[TBL] [Abstract] [Full Text] [Related]
18. Complexity of
Xerri T; Borg J; Casha R; Fsadni C
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34479876
[TBL] [Abstract] [Full Text] [Related]
19. Ouabain Induces DNA Damage in Human Osteosarcoma U-2 OS Cells and Alters the Expression of DNA Damage and DNA Repair-associated Proteins.
Yang JL; Yang MD; Chen JC; Lu KW; Huang YP; Peng SF; Chueh FS; Liu KC; Lin TS; Chen PY; Chen WJ
In Vivo; 2021; 35(5):2687-2696. PubMed ID: 34410957
[TBL] [Abstract] [Full Text] [Related]
20. A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin.
Moura DS; Peña-Chilet M; Cordero Varela JA; Alvarez-Alegret R; Agra-Pujol C; Izquierdo F; Ramos R; Ortega-Medina L; Martin-Davila F; Castilla-Ramirez C; Hernandez-Leon CN; Romagosa C; Vaz Salgado MA; Lavernia J; Bagué S; Mayodormo-Aranda E; Vicioso L; Hernández Barceló JE; Rubio-Casadevall J; de Juan A; Fiaño-Valverde MC; Hindi N; Lopez-Alvarez M; Lacerenza S; Dopazo J; Gutierrez A; Alvarez R; Valverde C; Martinez-Trufero J; Martín-Broto J
Mol Oncol; 2021 Dec; 15(12):3691-3705. PubMed ID: 33983674
[TBL] [Abstract] [Full Text] [Related]
[Next]
